Intact Investment Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-25,300
| Closed | -$1.37M | – | 222 |
|
|
2026
Q1 | $1.59M | Buy |
25,300
+10,000
| +65% | +$800K | 0.05% | 196 |
|
|
2025
Q4 | $1.46M | Buy |
15,300
+2,100
| +16% | +$206K | 0.04% | 201 |
|
|
2025
Q3 | $1.29M | Buy |
13,200
+1,700
| +15% | +$176K | 0.04% | 203 |
|
|
2025
Q2 | $1.24M | Buy |
11,500
+6,200
| +117% | +$627K | 0.04% | 213 |
|
|
2025
Q1 | $535K | Buy |
5,300
+400
| +8% | +$40.3K | 0.02% | 245 |
|
|
2024
Q4 | $438K | Sell |
4,900
-3,950
| -45% | -$348K | 0.02% | 245 |
|
|
2024
Q3 | $742K | Sell |
8,850
-1,050
| -11% | -$82.8K | 0.02% | 220 |
|
|
2024
Q2 | $762K | Sell |
9,900
-2,300
| -19% | -$168K | 0.03% | 214 |
|
|
2024
Q1 | $836K | Buy |
12,200
+500
| +4% | +$32.1K | 0.03% | 203 |
|
|
2023
Q4 | $676K | Sell |
11,700
-4,500
| -28% | -$240K | 0.03% | 211 |
|
|
2023
Q3 | $855K | Sell |
16,200
-300
| -2% | -$15.7K | 0.04% | 197 |
|
|
2023
Q2 | $892K | Sell |
16,500
-1,300
| -7% | -$67.9K | 0.04% | 197 |
|
|
2023
Q1 | $891K | Buy |
17,800
+1,200
| +7% | +$56.6K | 0.04% | 187 |
|
|
2022
Q4 | $768K | Sell |
16,600
-5,800
| -26% | -$251K | 0.03% | 189 |
|
|
2022
Q3 | $868K | Hold |
22,400
| – | – | 0.03% | 197 |
|
|
2022
Q2 | $835K | Hold |
22,400
| – | – | 0.03% | 195 |
|
|
2022
Q1 | $992K | Sell |
22,400
-2,800
| -11% | -$121K | 0.03% | 199 |
|
|
2021
Q4 | $1.07M | Hold |
25,200
| – | – | 0.03% | 199 |
|
|
2021
Q3 | $1.09M | Hold |
25,200
| – | – | 0.03% | 193 |
|
|
2021
Q2 | $1.08M | Sell |
25,200
-2,600
| -9% | -$109K | 0.03% | 188 |
|
|
2021
Q1 | $1.07M | Hold |
27,800
| – | – | 0.03% | 188 |
|
|
2020
Q4 | $999K | Hold |
27,800
| – | – | 0.03% | 201 |
|
|
2020
Q3 | $1.06M | Hold |
27,800
| – | – | 0.04% | 181 |
|
|
2020
Q2 | $976K | Buy |
27,800
+3,600
| +15% | +$130K | 0.04% | 184 |
|
|
2020
Q1 | $790K | Buy |
24,200
+4,000
| +20% | +$156K | 0.03% | 181 |
|
|
2019
Q4 | $913K | Buy |
20,200
+8,500
| +73% | +$356K | 0.03% | 188 |
|
|
2019
Q3 | $476K | Hold |
11,700
| – | – | 0.02% | 194 |
|
|
2019
Q2 | $503K | Hold |
11,700
| – | – | 0.02% | 192 |
|
|
2019
Q1 | $449K | Hold |
11,700
| – | – | 0.02% | 193 |
|
|
2018
Q4 | $413K | Hold |
11,700
| – | – | 0.02% | 187 |
|
|
2018
Q3 | $450K | Hold |
11,700
| – | – | 0.02% | 199 |
|
|
2018
Q2 | $383K | Hold |
11,700
| – | – | 0.01% | 201 |
|
|
2018
Q1 | $320K | Hold |
11,700
| – | – | 0.01% | 200 |
|
|
2017
Q4 | $290K | Buy |
+11,700
| New | +$323K | 0.01% | 192 |
|
|
2017
Q2 | – | Sell |
-11,700
| Closed | -$291K | – | 252 |
|
|
2017
Q1 | $291K | Sell |
11,700
-11,600
| -50% | -$282K | 0.01% | 228 |
|
|
2016
Q4 | $504K | Buy |
23,300
+13,400
| +135% | +$292K | 0.02% | 192 |
|
|
2016
Q3 | $236K | Buy |
+9,900
| New | +$236K | 0.01% | 249 |
|
Other funds holding BSX
Intact Investment Management's BSX Position: Q2 2026 in Review
Intact Investment Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 25,300 shares — an estimated $1.37M sold.
Intact Investment Management first reported a position in BSX in Q3 2016 and held it in 37 quarters. The position peaked at $1.59M in Q1 2026. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Intact Investment Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
- Intact Investment Management sold 25,300 Boston Scientific shares in Q2 2026, an estimated $1.37M.
- Intact Investment Management first reported a position in Boston Scientific in Q3 2016 and held it in 37 quarters.
- Intact Investment Management's Boston Scientific position peaked at $1.59M in Q1 2026.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Intact Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.